ABSTRACT
The central nervous system (CNS) is protected by a highly selective barrier, the blood-brain barrier (BBB), that regulates the exchange and homeostasis of bloodborne molecules, excluding xenobiotics. This barrier forms the first line of defense by prohibiting pathogens from crossing to the CNS. Aging and chronic exposure of the BBB to pathogens renders it permeable, and this may give rise to pathology in the CNS such as Alzheimer's disease (AD). Researchers have linked pathogens associated with periodontitis to neuroinflammation and AD-like pathology in vivo and in vitro. Although the presence of periodontitis-associated bacteria has been linked to AD in several clinical studies as DNA and virulence factors were confirmed in brain samples of human AD subjects, the mechanism by which the bacteria traverse to the brain and potentially influences neuropathology is unknown. In this review, we present current knowledge about the association between periodontitis and AD, the mechanism whereby periodontal pathogens might provoke neuroinflammation and how periodontal pathogens could affect the BBB. We suggest future studies, with emphasis on the use of human in vitro models of cells associated with the BBB to unravel the pathway of entry for these bacteria to the CNS and to reveal the molecular and cellular pathways involved in initiating the AD-like pathology. In conclusion, evidence demonstrates that bacteria associated with periodontitis and their virulence factors are capable of inflecting damage to the BBB and have a role in giving rise to pathology similar to that found in AD.
Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Blood-Brain Barrier/metabolism , Periodontitis , Virulence Factors , Alzheimer Disease/blood , Animals , Biological Transport , Brain/metabolism , Brain/pathology , Humans , Periodontitis/complications , Periodontitis/metabolism , Virulence Factors/bloodABSTRACT
Quorum sensing (QS) is the ability of some bacteria to detect and to respond to population density through signalling molecules. QS molecules are involved in motility and cell aggregation mechanisms in diseases such as sepsis. Few biomarkers are currently available to diagnose sepsis, especially in high-risk conditions. The aim of this study was the development of new analytical methods based on liquid chromatography-mass spectrometry for the detection and quantification of QS signalling molecules, including N-acyl homoserine lactones (AHL) and hydroxyquinolones (HQ), in biofluids. Biological samples used in the study were Pseudomonas aeruginosa bacterial cultures and plasma from patients with sepsis. We developed two MS analytical methods, based on neutral loss (NL) and product ion (PI) experiments, to identify and characterize unknown AHL and HQ molecules. We then established a multiple-reaction-monitoring (MRM) method to quantify specific QS compounds. We validated the HPLC-MS-based approaches (MRM-NL-PI), and data were in accord with the validation guidelines. With the NL and PI MS-based methods, we identified and characterized 3 and 13 unknown AHL and HQ compounds, respectively, in biological samples. One of the newly found AHL molecules was C12-AHL, first quantified in Pseudomonas aeruginosa bacterial cultures. The MRM quantitation of analytes in plasma from patients with sepsis confirmed the analytical ability of MRM for the quantification of virulence factors during sepsis. Graphical abstract.
Subject(s)
Acyl-Butyrolactones/analysis , Chromatography, High Pressure Liquid/methods , Mass Spectrometry/methods , Pseudomonas aeruginosa/metabolism , Quinolones/analysis , Quorum Sensing , Signal Transduction , Acyl-Butyrolactones/chemistry , Humans , Limit of Detection , Molecular Structure , Multiple Organ Failure/blood , Multiple Organ Failure/etiology , Quinolones/chemistry , Reproducibility of Results , Sepsis/blood , Sepsis/complications , Sepsis/microbiology , Virulence Factors/bloodABSTRACT
A total of 714 pediatric cases of Staphylococcus aureus bacteremia were identified from 2008 to 2015 in Denmark; 98% were methicillin-susceptible S. aureus (MSSA). Fifteen isolates (2,1%) were Panton-Valentine leucocidin positive (0.17/100,000 children/year) and 87% MSSA. Eight cases (53%) were severe, including all pneumonia cases. Panton-Valentine leucocidin positive Staphylococcus aureus bacteremia is rare in our setting with high MSSA-prevalence. Half of the cases were uncomplicated.
Subject(s)
Bacteremia/epidemiology , Bacterial Toxins/blood , Exotoxins/blood , Leukocidins/blood , Staphylococcal Infections/blood , Staphylococcal Infections/epidemiology , Staphylococcus aureus/pathogenicity , Virulence Factors/blood , Adolescent , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Child , Denmark/epidemiology , Humans , Infant , Infant, Newborn , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Prevalence , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effectsABSTRACT
BACKGROUND: Lethal and edema toxins are critical virulence factors of Bacillus anthracis. Few data are available on their presence in the early stage of intranasal infection. METHODS: To investigate the diffusion of edema factor (EF) and lethal factor (LF), we use sensitive quantitative methods to measure their enzymatic activities in mice intranasally challenged with a wild-type B anthracis strain or with an isogenic mutant deficient for the protective antigen. RESULTS: One hour after mouse challenge, although only 7% of mice presented bacteremia, LF and EF were detected in the blood of 100% and 42% of mice, respectively. Protective antigen facilitated the diffusion of LF and EF into the blood compartment. Toxins played a significant role in the systemic dissemination of B anthracis in the blood, spleen, and liver. A mouse model of intoxination further confirmed that LT and ET could diffuse rapidly in the circulation, independently of bacteria. CONCLUSIONS: In this inhalational model, toxins have disseminated rapidly in the blood, playing a significant and novel role in the early systemic diffusion of bacteria, demonstrating that they may represent a very early target for the diagnosis and the treatment of anthrax.
Subject(s)
Anthrax/metabolism , Antigens, Bacterial/blood , Bacillus anthracis/pathogenicity , Bacterial Toxins/blood , Nasal Absorption , Virulence Factors/blood , Animals , Animals, Outbred Strains , Anthrax/microbiology , Bacillus anthracis/enzymology , Bacteremia , Biomarkers/blood , Disease Models, Animal , Enzyme Activation , Enzyme Assays , Female , Mice , VirulenceABSTRACT
trans-Sialidase and cruzipain are important virulence factors from Trypanosoma cruzi, the etiological agent of Chagas disease, that have highly antigenic domains in their structure and were reported as potential tools for diagnosis of the illness. The aim of the present study is to assess the possibility of using cruzipain and the catalytic domain of trans-sialidase in a Surface Plasmon Resonance-based immunosensor for the diagnosis of chronic Chagas disease. Immunoassays carried out with canine sera verified that cruzipain allows the detection of anti-Trypanosoma cruzi antibodies whereas recombinant trans-sialidase did not yield specific detections, due to the high dilutions of serum used in the immunoassays that hinder the possibility to sense the specific low titer antibodies. The developed cruzipain-based biosensor, whose price per assay is comparable to a commercial enzyme-linked immunosorbent assay (ELISA), was successfully applied for the rapid quantification of specific antibodies against Trypanosoma cruzi in fresh human sera showing an excellent agreement with ELISA.
Subject(s)
Antibodies, Protozoan/blood , Chagas Disease/diagnosis , Chagas Disease/veterinary , Enzyme-Linked Immunosorbent Assay/methods , Trypanosoma cruzi/isolation & purification , Animals , Chagas Disease/blood , Chagas Disease/parasitology , Cysteine Endopeptidases/analysis , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/immunology , Dog Diseases/blood , Dog Diseases/diagnosis , Dog Diseases/parasitology , Dogs , Glycoproteins/analysis , Glycoproteins/genetics , Glycoproteins/immunology , Humans , Neuraminidase/analysis , Neuraminidase/genetics , Neuraminidase/immunology , Protozoan Proteins/analysis , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Trypanosoma cruzi/genetics , Trypanosoma cruzi/immunology , Virulence Factors/blood , Virulence Factors/genetics , Virulence Factors/immunologyABSTRACT
α-Haemolysin (HlyA) from uropathogenic Escherichia coli has been demonstrated to be a significant virulence factor for ascending urinary tract infections. Once the E. coli reach the well-vascularised kidneys, there is a high risk of bacteraemia and a subsequent septic host response. Despite this, HlyA has the potential to accelerate the host response both directly and via its ability to facilitate adenosine triphosphate release from cells. It has not been settled whether HlyA aggravates bacteraemia into a septic state. To address this, we used an E. coli strain in a model of acute urosepsis that was either transfected with a plasmid containing the full HlyA operon or one with deletion in the HlyA gene. Here, we show that HlyA accelerates the host response to E. coli in the circulation. Mice exposed to HlyA-producing E. coli showed massively increased proinflammatory cytokines, a substantial fall in circulating thrombocytes, extensive haematuria, and intravascular haemolysis. This was not seen in mice exposed to either E. coli that do not secrete HlyA or vehicle controls. Consistent with the massive host response to the bacteria, the mice exposed to HlyA-producing E. coli died exceedingly early, whereas mice exposed to E. coli without HlyA production and vehicle controls survived the entire observation period. These data allow us to conclude that HlyA is a virulence factor that accelerates a state of bacteraemia into fulminant sepsis in a mouse model.
Subject(s)
Bacteremia/microbiology , Escherichia coli Infections/microbiology , Escherichia coli Proteins/blood , Hemolysin Proteins/blood , Urinary Tract Infections/microbiology , Uropathogenic Escherichia coli/pathogenicity , Virulence Factors/blood , Animals , Bacteremia/blood , Bacteremia/mortality , Blood Platelets/metabolism , Cytokines/blood , Disease Models, Animal , Erythrocytes/metabolism , Erythrocytes/microbiology , Erythrocytes/pathology , Escherichia coli Infections/blood , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Gene Expression , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Hemolysis , Humans , Male , Mice , Mice, Inbred BALB C , Operon , Urinary Tract Infections/blood , Uropathogenic Escherichia coli/metabolism , Virulence Factors/geneticsABSTRACT
Pyocyanin (PCN) is a virulence factor secreted by Pseudomonas aeruginosa (P. aeruginosa) that has been shown to have numerous toxic effects in both in vitro and in vivo studies. Such toxicities include pro-inflammatory and pro-oxidant mediated responses. It is hypothesized that PCN can cross biological membranes and reach the systemic circulation, but no previous studies have investigated this. The aim of this study was, therefore, to quantify PCN in plasma and assess if systemic responses were occurring after localized intranasal administration in C57BL/6 J mice. This was achieved through the plasma quantification of PCN and assessment of changes to behavior using two commonly used tests, the forced swimming test and the open field test. Furthermore, evidence of systemic oxidative stress and inflammation was measured using malondialdehyde (MDA) and TNF-α post PCN exposure. PCN was found to cross into systemic circulation but in a variable manner. Furthermore, significant increases in plasma TNF-α and MDA (both p < 0.001) were observed along with changes in behavior indicative of systemic inflammatory responses.
Subject(s)
Behavior, Animal/drug effects , Malondialdehyde/blood , Oxidative Stress/drug effects , Pyocyanine/toxicity , Tumor Necrosis Factor-alpha/blood , Virulence Factors/toxicity , Administration, Intranasal , Animals , Inflammation , Male , Mice, Inbred C57BL , Motor Activity/drug effects , Pseudomonas aeruginosa/pathogenicity , Pyocyanine/blood , Swimming , Virulence Factors/bloodABSTRACT
Helicobacter pylori infection shows a worldwide prevalence of around 50%. However, only a minority of infected individuals develop clinical symptoms or diseases. The presence of H. pylori virulence factors, such as CagA and VacA, has been associated with disease development, but assessment of virulence factor presence requires gastric biopsies. Here, we evaluate the H. pylori recomLine test for risk stratification of infected patients by comparing the test score and immune recognition of type I or type II strains defined by the virulence factors CagA, VacA, GroEL, UreA, HcpC, and gGT with patient's disease status according to histology. Moreover, the immune responses of eradicated individuals from two different populations were analysed. Their immune response frequencies and intensities against all antigens except CagA declined below the detection limit. CagA was particularly long lasting in both independent populations. An isolated CagA band often represents past eradication with a likelihood of 88.7%. In addition, a high recomLine score was significantly associated with high-grade gastritis, atrophy, intestinal metaplasia, and gastric cancer. Thus, the recomLine is a sensitive and specific noninvasive test for detecting serum responses against H. pylori in actively infected and eradicated individuals. Moreover, it allows stratifying patients according to their disease state.
Subject(s)
Gastritis/immunology , Gastritis/microbiology , Helicobacter Infections/immunology , Helicobacter Infections/microbiology , Helicobacter pylori/pathogenicity , Immunoassay/methods , Adolescent , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/immunology , Antigens, Bacterial/isolation & purification , Bacterial Proteins/immunology , Bacterial Proteins/isolation & purification , Biopsy , Female , Gastritis/blood , Gastritis/diagnosis , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter pylori/classification , Helicobacter pylori/immunology , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Sensitivity and Specificity , Serologic Tests/methods , Stomach/microbiology , Stomach/pathology , Stomach Neoplasms/etiology , Stomach Neoplasms/microbiology , Virulence Factors/blood , Young AdultABSTRACT
BACKGROUND: Mixed cryoglobulinemia (MC) is a rare multisystem disease whose aetiopathogenesis is not completely understood. Hepatitis C virus (HCV) infection may have a causative role, and genetic and/or environmental factors may also contribute. AIMS: To investigate the presence and possible role of environmental agents in MC. METHODS: We recruited 30 HCV-infected MC patients with different clinical manifestations and a control group of 30 healthy, sex-/age-matched volunteers. We collected serum samples from each patient and incubated at 4°C for 7 days to obtain cryoprecipitate samples. We used environmental scanning electron microscopy (ESEM) and energy dispersive X-ray spectroscopy microanalysis to verify the presence of microparticles (MPs) and nanoparticles (NPs) in serum and cryoprecipitate samples. We evaluated environmental exposure using a medical and occupational history questionnaire for each subject. RESULTS: MC patients had a significantly higher risk of occupational exposure (OR 5.6; 95% CI 1.84-17.50) than controls. ESEM evaluation revealed a significantly higher concentration, expressed as number of positive spots (NS), of serum inorganic particles in MC patients compared with controls (mean NS 18, SD = 16 versus NS 5.4, SD = 5.1; P < 0.05). Cryoprecipitate samples of MC patients showed high concentrations of inorganic particles (mean NS 49, SD = 19). We found a strong correlation between NS and cryocrit (i.e. percentage of cryoprecipitate/total serum after centrifugation at 4°C) levels (P < 0.001). CONCLUSIONS: In addition to HCV infection, MPs and NPs might play an important role in the aetiopathogenesis of MC.
Subject(s)
Cryoglobulinemia/physiopathology , Nanoparticles/analysis , Virulence Factors/blood , Adult , Aged , Aged, 80 and over , Cryoglobulinemia/blood , Cryoglobulinemia/diagnosis , Female , Hepacivirus/pathogenicity , Hepatitis C/blood , Hepatitis C/physiopathology , Humans , Male , Middle AgedABSTRACT
BACKGROUND: The inflammatory response directed against Helicobacter pylori (HP) is believed to be one of the main triggers of the appearance of gastric lesions and their progression to gastric cancer (GC). Epstein-Barr virus (EBV) has been found responsible for about 10% of all GCs, but the inflammatory response has not been studied in GC patients with evidence of high levels of EBV reactivation. OBJECTIVE: To determine the relationship between inflammation and antibodies against EBV reactivation antigens, HP, and the bacterium virulence factor CagA in patients with GC. METHODS: 127 GC patients, 46 gastritis patients, and 197 healthy subjects were studied. IL-1ß, IL-6, IL-8, IL-10, TNF-α, TGF-ß, MCP-1, and IFN-γ levels were measured in serum or plasma and compared against the antibody titers of VCA-IgG, HP, and the HP virulence factor CagA. Statistical associations were estimated. RESULTS: Significant ORs and positive trends were found between VCA-IgG and IFN-γ, specifically for patients with GC of intestinal type (OR: 6.4, 95% C.I. 1.2-35.4) (p < 0.044). CONCLUSIONS: We confirmed a positive association between a marker of EBV reactivation and intestinal gastric cancer and present evidence of a correlation with elevated serum levels of IFN-γ, but not with the other cytokines.
Subject(s)
Epstein-Barr Virus Infections/immunology , Helicobacter Infections/immunology , Helicobacter pylori/physiology , Herpesvirus 4, Human/physiology , Interferon-gamma/metabolism , Intestines/pathology , Stomach Neoplasms/immunology , Adult , Aged , Antibodies, Viral/blood , Antigens, Bacterial/blood , Antigens, Viral/immunology , Bacterial Proteins/blood , Biomarkers, Tumor/blood , Capsid Proteins/immunology , Cross-Sectional Studies , Epstein-Barr Virus Infections/virology , Female , Helicobacter Infections/virology , Humans , Male , Middle Aged , Stomach Neoplasms/virology , Up-Regulation , Virulence Factors/blood , Virus Activation , Young AdultABSTRACT
Recombinant immunotoxins (RITs) are fusions of an Fv-based targeting moiety and a toxin. Pseudomonas exotoxin A (PE) has been used to make several immunotoxins that have been evaluated in clinical trials. Immunogenicity of the bacterial toxin and off-target toxicity have limited the efficacy of these immunotoxins. To address these issues, we have previously made RITs in which the Fv is connected to domain III (PE24) by a furin cleavage site (FCS), thereby removing unneeded sequences of domain II. However, the PE24 containing RITs do not contain the naturally occurring disulfide bond around the furin cleavage sequence, because it was removed when domain II was deleted. This could potentially allow PE24 containing immunotoxins to be cleaved and inactivated before internalization by cell surface furin or other proteases in the blood stream or tumor microenvironment. Here, we describe five new RITs in which a disulfide bond is engineered to protect the FCS. The most active of these, SS1-Fab-DS3-PE24, shows a longer serum half-life than an RIT without the disulfide bond and has the same anti-tumor activity, despite being less cytotoxic in vitro. These results have significance for the production of de-immunized, low toxicity, PE24-based immunotoxins with a longer serum half-life.
Subject(s)
ADP Ribose Transferases/pharmacology , Bacterial Toxins/pharmacology , Cell Proliferation/drug effects , Disulfides/pharmacology , Drug Design , Exotoxins/pharmacology , Furin/metabolism , Immunoglobulin Variable Region/pharmacology , Immunotoxins/pharmacology , Neoplasms/drug therapy , Virulence Factors/pharmacology , ADP Ribose Transferases/blood , ADP Ribose Transferases/chemistry , Animals , Bacterial Toxins/blood , Bacterial Toxins/chemistry , Cell Line, Tumor , Disulfides/blood , Disulfides/chemistry , Dose-Response Relationship, Drug , Drug Stability , Exotoxins/blood , Exotoxins/chemistry , Half-Life , Humans , Immunoglobulin Variable Region/blood , Immunoglobulin Variable Region/chemistry , Immunotoxins/blood , Immunotoxins/chemistry , Inhibitory Concentration 50 , Mesothelin , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasms/pathology , Oxidation-Reduction , Protein Domains , Recombinant Proteins/blood , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Structure-Activity Relationship , Tumor Microenvironment , Virulence Factors/blood , Virulence Factors/chemistry , Xenograft Model Antitumor Assays , Pseudomonas aeruginosa Exotoxin AABSTRACT
Recently, different bacteriological laboratory interventions that decrease reporting time have been developed. These promising new broad-based techniques have merit, based on their ability to identify rapidly many bacteria, organisms difficult to grow or newly emerging strains, as well as their capacity to track disease transmission. Maldi-TOF MS has been proven to be an accurate and reliable method for organism identification including bacteria, yeast, molds, and mycobacteria. It is rapid, with results often 24 hours earlier than traditional methods, and inexpensive. The range of applications of Maldi-TOF MS has been growing constantly, from rapid species identification to labor-intensive proteomic studies of bacterial physiology (bacterial resistance and virulence). The purpose of this review is to present the different solutions commercialized in France, summarize the place of this technology in microbiology lab and to analyze future perspectives in this field.
Subject(s)
Bacteriological Techniques/methods , Mass Spectrometry/methods , Bacterial Infections/diagnosis , Bacterial Infections/microbiology , Bacteriological Techniques/instrumentation , Bacteriology/instrumentation , Humans , Polymerase Chain Reaction/methods , Protein Array Analysis/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Virulence Factors/analysis , Virulence Factors/bloodABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen in many hospitals and long-term care facilities as well as in the community. To limit the spread of MRSA, early detection and proper treatment are essential. Because conventional culture as gold standard is time consuming, new techniques such as PCR-based and hybridization assays have emerged for the rapid detection of MRSA. This review will focus on the currently available molecular-based assays and on their utility and performance for detection of S. aureus, of its virulence factors and of the markers for acquired resistance.
Subject(s)
Methicillin Resistance/genetics , Methicillin-Resistant Staphylococcus aureus/genetics , Molecular Diagnostic Techniques/methods , Staphylococcal Infections/diagnosis , Staphylococcal Infections/genetics , Virulence Factors/genetics , Biomarkers/blood , Humans , Iatrogenic Disease , Methicillin-Resistant Staphylococcus aureus/metabolism , Methicillin-Resistant Staphylococcus aureus/pathogenicity , Staphylococcal Infections/blood , Virulence Factors/bloodABSTRACT
Rhodococcus equi is the most common cause of pneumonia in young foals. A vaccine is not available and the use of R equi-specific hyperimmune plasma (HIP) is common. Despite its widespread use, the efficacy of HIP in preventing disease remains controversial. The objectives of this study were (1) to evaluate the virulence associate protein A (VapA)-specific IgG and IgG subclasses in commercially available R equi HIP and (2) to evaluate serum VapA-specific IgG and IgG subclasses in foals following administration of commercial R equi HIP. Three different lots from four commercial R equi HIP were sampled. VapA-specific IgG and IgG subclasses were evaluated in all samples using an ELISA. Serum was collected from newborn foals either after commercial R equi HIP was administered (n=97) or not (n=70). Serum was also collected from each mare. Administration of HIP significantly (P<0.001) increased VapA-specific IgGs in recipient foals, however, there was a marked variation in VapA-specific IgGs in foals receiving the same product. VapA-specific IgGs were significantly different (P<0.001) between products and varied between lots, with coefficients of variation ranging from 17 to 123 per cent. These results may explain previously reported disparities in HIP efficacy.
Subject(s)
Animals, Newborn/immunology , Bacterial Proteins/immunology , Horse Diseases/prevention & control , Immunoglobulin G/blood , Plasma/immunology , Rhodococcus equi/immunology , Virulence Factors/immunology , Animals , Animals, Newborn/blood , Antibodies, Bacterial/blood , Bacterial Proteins/blood , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Horses , Pneumonia, Bacterial/prevention & control , Pneumonia, Bacterial/veterinary , Virulence Factors/bloodABSTRACT
In endemic regions, Lyme disease is a potential health threat to dogs. Canine Lyme disease manifests with arthritis-induced lameness, anorexia, fever, lethargy, lymphadenopathy and, in some cases, fatal glomerulonephritis. A recent study revealed that the regional mean for the percentage of seropositive dogs in the north-east of the USA is 11.6%. The outer surface protein C (OspC) of Lyme disease spirochetes is an important virulence factor required for the establishment of infection in mammals. It is a leading candidate in human and canine Lyme disease vaccine development efforts. Over 30 distinct ospC phyletic types have been defined. It has been hypothesized that ospC genotype may influence mammalian host range. In this study, Ixodes scapularis ticks collected from the field in Rhode Island were assessed for infection with B. burgdorferi. Ticks were fed on purpose bred beagles to repletion and infection of the dogs was assessed through serology and PCR. Tissue biopsies (n=2) were collected from each dog 49 days post-tick infestation (dpi) and the ospC genotype of the infecting strains determined by direct PCR of DNA extracted from tissue or by PCR after cultivation of spirochetes from biopsy samples. The dominant ospC types associated with B. burgdorferi canine infections differed from those associated with human infection, indicating a relationship between ospC sequence and preferred host range. Knowledge of the most common ospC genotypes associated specifically with infection of dogs will facilitate the rational design of OspC-based canine Lyme disease vaccines and diagnostic assays.
Subject(s)
Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Bacterial Vaccines/immunology , Borrelia burgdorferi/immunology , Dog Diseases/microbiology , Dog Diseases/parasitology , Lyme Disease/veterinary , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/genetics , Antibodies, Bacterial/metabolism , Antigens, Bacterial/metabolism , Bacterial Outer Membrane Proteins/metabolism , Bacterial Vaccines/genetics , Bacterial Vaccines/metabolism , Borrelia burgdorferi/genetics , Borrelia burgdorferi/isolation & purification , Dogs , Genotype , Ixodes/microbiology , Ixodes/physiology , Lyme Disease/microbiology , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction/veterinary , Rhode Island , Sequence Analysis, DNA/veterinary , Tick Infestations/parasitology , Tick Infestations/veterinary , Virulence Factors/blood , Virulence Factors/genetics , Virulence Factors/metabolismABSTRACT
In cystic fibrosis (CF), if Pseudomonas aeruginosa (Pa) infection is not diagnosed and treated early, chronic colonization occurs, which causes rapid decline in pulmonary functions. The aim of this study was to evaluate Pa antibodies, compare them with Pa cultures and determine their role in early diagnosis and follow-up. Ninety CF patients were included; they were divided into chronic, intermittent, negative, and mucoid groups. They were evaluated every 3-6 months. In each visit, pulmonary function tests and sputum cultures were obtained, and Pa antibodies exotoxin A (ExoA), elastase (ELA) and alkaline protease (AP) were determined in the serum by enzyme-linked immunosorbent assay (ELISA). The most specific test that discriminated chronic colonized patients from noncolonized patients was Pa culture, and the presence of at least one antibody had the highest sensitivity. AP had the highest specificity, and ELA had the highest sensitivity. All antibodies were highest in the mucoid group. ELA was highest in chronic and lowest in the negative group. The presence of antibodies was much higher than positive Pa cultures in patients younger than five years of age. A negative correlation between forced expiratory volume in 1 second (FEV1) and AP was determined only in the mucoid group. In the two-year follow-up, antibody presence did not show a regular pattern. In CF, Pa antibodies can be early markers for diagnosis, especially in young children who cannot expectorate, but they should only be used together with sputum cultures for long-term follow-up and treatment.
Subject(s)
Antibodies, Bacterial/blood , Cystic Fibrosis/diagnosis , Pseudomonas aeruginosa/immunology , ADP Ribose Transferases/blood , Adolescent , Adult , Bacterial Proteins/blood , Bacterial Toxins/blood , Child , Child, Preschool , Continuity of Patient Care , Endopeptidases/blood , Enzyme-Linked Immunosorbent Assay , Exotoxins/blood , Female , Humans , Infant , Male , Pancreatic Elastase/blood , Respiratory Function Tests , Virulence Factors/blood , Young Adult , Pseudomonas aeruginosa Exotoxin AABSTRACT
Ruminants, especially cattle, have been implicated as a principal reservoir of one of the enterovirulent Escherichia coli pathotypes. The detection of the virulence genes in diarrhoeic calves and small ruminants has not been studied in Egypt. To determine the occurrence, serotypes and the virulence gene markers, stx1, stx2, hylA, Flic(h7) , stb, F41, K99, sta, F17, LT-I, LT-II and eae, rectal swabs were taken from diarrhoeic calves, sheep and goats and subjected to bacterial culture and PCR. The E. coli prevalence rate in the diarrhoeic animals was 63.6% in calves, 27.3% in goat and 9.1% in sheep. The 102 E. coli strains isolated from the calves, goat and sheep were 100% haemolytic non-verotoxic and fitted into the Eagg group. The isolates belonged to seven O serogroups (O25, O78, O86, O119, O158, O164 and O157). The eae gene was detected in six of the strains isolated from the calves. The 102 bovine, ovine and caprine E. coli strains isolated in this study were negative for stx1, stx2, F41, LT-I and Flic(h7) genes. The highest gene combinations were found to occur in the form of 24/102 isolates (23.5%) that carried the F17 gene predominantly associated with eaeA, hylA, K99 and Stb genes in the calves, while the hylA, K99 and Sta were the only genes found to be in conjunction in both calves and goats (6/102; 5.9% each). Our data show that in Egypt, large and small ruminants could be a potential source of infection in humans.
Subject(s)
Diarrhea/veterinary , Escherichia coli Infections/veterinary , Escherichia coli/pathogenicity , Feces/microbiology , Genes, Bacterial , Virulence Factors/genetics , Agglutination Tests , Animals , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/microbiology , Diarrhea/epidemiology , Diarrhea/microbiology , Egypt/epidemiology , Escherichia coli/genetics , Escherichia coli/isolation & purification , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Goat Diseases/epidemiology , Goat Diseases/microbiology , Goats , Hemolysis , Polymerase Chain Reaction , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/microbiology , Virulence/genetics , Virulence Factors/bloodABSTRACT
The virulence factor gliotoxin (GT) and its inactive derivative, bis(methylthio)gliotoxin (bmGT), are produced by pathogens of the genus Aspergillus. Here we report the detection of GT and bmGT in serum of humans at risk of invasive aspergillosis (IA) as well as in cultures of fungal isolates derived from patients with proven infection with A. fumigatus. Although both compounds are readily recoverable from spiked human serum or plasma, only bmGT is retained in whole blood, indicating that bmGT may be the better marker for in vivo detection. Accordingly, bmGT was found more frequently than GT in samples from patients at risk of IA and incultures of clinical isolates of A. fumigatus. In some cases, bmGT was detected before mycologic evidence ofinfection was gained. Importantly, neither GT nor bmGT was found in serum from healthy donors or from neutropenic patients without any sign of infection. Thus, bmGT presence might provide a more reliable indicator of A. fumigatus infections than GT. Due to its simplicity and sensitivity, a diagnostic technology based on this test could be easily adopted in clinical laboratories to help in the diagnosis of this often fatal fungal infection.
Subject(s)
Aspergillosis/diagnosis , Aspergillus fumigatus/isolation & purification , Gliotoxin/analogs & derivatives , Gliotoxin/blood , Aspergillus fumigatus/metabolism , Blood Chemical Analysis , Culture Media/chemistry , Humans , Sensitivity and Specificity , Virulence Factors/bloodABSTRACT
Antibodies that recognize microbial B lymphocyte superantigenic epitopes are produced constitutively with no requirement for adaptive immune maturation. We report cleavage of the Staphylococcus aureus virulence factor extracellular fibrinogen-binding protein (Efb) by catalytic antibodies produced with no exposure to the bacterium and reduction of the catalytic antibody activity following infection. IgG catalytic antibodies that specifically hydrolyzed Efb via a nucleophilic catalytic mechanism were found in the blood of healthy humans and aseptic mice free of S. aureus infection. IgG hydrolyzed peptide bonds on the C-terminal side of basic amino acids, including a bond located within the C3b-binding domain of Efb. Efb digested with the IgG lost its ability to bind C3b and inhibit complement-dependent antibody-mediated red blood cell lysis. In addition to catalysis, the IgG expressed saturable Efb binding activity. IgG from S. aureus-infected mice displayed reduced Efb cleaving activity and increased Efb binding activity compared with uninfected controls, suggesting differing effects of the infection on the antibody subsets responsible for the two activities. IgG from children hospitalized for S. aureus infection also displayed reduced Efb cleavage compared with healthy children. These data suggest a potential defense function for constitutively produced catalytic antibodies to a putative superantigenic site of Efb, but an adaptive catalytic response appears to be proscribed.
Subject(s)
Antibodies, Bacterial/immunology , Antibodies, Catalytic/immunology , Immunoglobulin G/immunology , Proteolysis , Staphylococcal Infections/immunology , Staphylococcus aureus , Virulence Factors/immunology , Adaptive Immunity/physiology , Adult , Amino Acid Sequence , Animals , Antibodies, Bacterial/blood , Antibodies, Catalytic/blood , Bacterial Proteins , Child , Child, Preschool , Female , Humans , Immunoglobulin G/blood , Male , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Protein Structure, Tertiary , Staphylococcal Infections/blood , Staphylococcus aureus/immunology , Staphylococcus aureus/pathogenicity , Virulence Factors/bloodABSTRACT
Tannerella forsythia is a poorly studied pathogen despite being one of the main causes of periodontitis, which is an inflammatory disease of the supporting structures of the teeth. We found that despite being recognized by all complement pathways, T. forsythia is resistant to killing by human complement, which is present at up to 70% of serum concentration in gingival crevicular fluid. Incubation of human serum with karilysin, a metalloproteinase of T. forsythia, resulted in a decrease in bactericidal activity of the serum. T. forsythia strains expressing karilysin at higher levels were more resistant than low-expressing strains. Furthermore, the low-expressing strain was significantly more opsonized with activated complement factor 3 and membrane attack complex from serum compared with the other strains. The high-expressing strain was more resistant to killing in human blood. The protective effect of karilysin against serum bactericidal activity was attributable to its ability to inhibit complement at several stages. The classical and lectin complement pathways were inhibited because of the efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3, and C4 by karilysin, whereas inhibition of the terminal pathway was caused by degradation of C5. Interestingly, karilysin was able to release biologically active C5a peptide in human plasma and induce migration of neutrophils. Importantly, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythia obtained from patients with periodontitis. Taken together, the newly characterized karilysin appears to be an important virulence factor of T. forsythia and might have several important implications for immune evasion.